Latest Capital Markets News

Predictive Discovery Limited and Robex Resources Inc. have agreed to merge, creating a mid-tier gold producer in West Africa with combined output expected to exceed 400,000 ounces annually by 2029.

North Stawell Minerals has confirmed Campbell Olsen as its permanent part-time CEO, aiming to leverage his expertise to advance exploration in the Stawell Mineralised Corridor.

Equity Story Group Ltd has voluntarily suspended trading of its shares pending a forthcoming announcement about a capital raise, signaling a significant funding event.

4DMedical has secured $22.6 million through the exercise of deep in-the-money options, significantly strengthening its cash position to support the commercial rollout of its CT – VQ™ respiratory imaging technology.

NexGen Energy has expanded its Australian equity offering to AUD 600 million alongside a concurrent C$400 million North American deal, aiming to accelerate development of its flagship Rook I uranium project.

NexGen Energy has launched a dual equity offering, raising approximately C$400 million in North America and AUD 400 million in Australia to advance its flagship Rook I uranium project and support corporate growth.

Orion Minerals Ltd has been reinstated to ASX quotation following the release of its 2025 annual report and a new capital raising announcement, ending its trading suspension.

Saturn Metals has raised $45 million through a share placement to accelerate exploration and development at its Apollo Hill Gold Project in Western Australia, aiming for key feasibility milestones by 2026.

Podium Minerals has announced a major metallurgical breakthrough with a new concentrator flowsheet achieving approximately 80% recovery of key platinum group metals, advancing its Parks Reef Project towards commercialisation.

Judo Bank has successfully priced a $150 million Tier 2 subordinated notes issuance with a significantly tighter margin, reflecting its strengthened credit profile and strong investor demand.

EMVision Medical Devices has launched a Share Purchase Plan allowing shareholders to invest up to A$30,000 at $1.94 per share, sweetened by free-attaching options exercisable at $3.40 each.

Uscom Limited has struck a deal to sell its entire business to Singapore-based AXO Medtech VCC for $2.59 million, aiming to unlock capital for growth under new ownership. Shareholder approval is the next critical step before the transaction can proceed.